Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

Yael L. Maxwell

December 15, 2025

FDA Expands Evolut Indication to Include Redo TAVI

News Daily News

FDA Expands Evolut Indications to Include Redo TAVI

Yael L. Maxwell

August 29, 2025

News Daily News

FDA Approves Cordella Remote PA Pressure Monitoring System for HF

Yael L. Maxwell

June 24, 2024

News Daily News

FDA Approves First Extravascular ICD

Yael L. Maxwell

October 23, 2023

News Daily News

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Yael L. Maxwell

July 09, 2021

News Daily News

FDA Approves Harmony TPV for Pulmonary-Valve Regurgitation in Congenital HD

Yael L. Maxwell

March 26, 2021

News Daily News

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

Yael L. Maxwell

May 16, 2019

News Daily News

FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients

Yael L. Maxwell

December 05, 2018

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

Yael L. Maxwell

February 26, 2018

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

News Daily News

La FDA Aprueba el Oclusor del FOP Amplatzer para la Prevención de ACV Recurrentes

Yael L. Maxwell

October 28, 2016

News Daily News

FDA 批准 PFO 封堵器用于预防中风复发

Yael L. Maxwell

October 28, 2016

News Daily News

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Yael L. Maxwell

October 28, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

Advertisement

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

FDA Expands Evolut Indications to Include Redo TAVI

FDA Approves Cordella Remote PA Pressure Monitoring System for HF

FDA Approves First Extravascular ICD

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

FDA Approves Harmony TPV for Pulmonary-Valve Regurgitation in Congenital HD

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

La FDA Aprueba el Oclusor del FOP Amplatzer para la Prevención de ACV Recurrentes

FDA 批准 PFO 封堵器用于预防中风复发

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content